Skip to main content
. 2022 Feb 2;9(2):210705. doi: 10.1098/rsos.210705

Figure 5.

Figure 5.

IFN-β administration schedule under different initial conditions Q1, Q2, Q3, Q4 and corresponding dynamics of (a) C, I, S and (b) N2/N1 levels. Administration of IFN-β lowers the N2/N1 levels.